Joined May 2020
June 24, 2021
COVID-19-vaccination in patients receiving allergen immunotherapy (AIT) or biologics...
Marek Jutel, María José Torres, Oscar Palomares, et al.
May 20, 2021
Advances and highlights in biomarkers of allergic diseases
Ismail Ogulur, Yağız Pat, Ozge Ardicli, et al.
March 31, 2021
T regulatory cells from asthmatic individuals show a Th2-like phenotype
Kirstin Jansen, Oliver Wirz, Willem van de Veen, et al.
February 18, 2021
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis w...
Ioana Agache, Yang Song, Pablo Alonso-Coello, et al.
December 28, 2020
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines -- an EAACI-AR...
Ludger Klimek, Marek Jutel, Cezmi Akdis, et al.
October 08, 2020
Risk factors for severe and critically ill COVID-19 patients: a review
Ya-dong Gao, Mei Ding, Xiang Dong, et al.
August 24, 2020
Advances and Recent Developments in Asthma in 2020
Lacin Cevhertas, Ismail Ogulur, debbie maurer, et al.
July 08, 2020
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systemat...
Ioana Agache, Yang Song, Margarita Posso, et al.
July 08, 2020
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria- a...
Ioana Agache, Claudio Rocha, Yang Song, et al.
June 22, 2020
Role of Nuclear Factor of Activated T cells 2 (NFATc2) in allergic asthma
Marielena Jakobi, Alexander Kiefer, Hooman Mirzakhani , et al.
June 08, 2020
Clinical, radiological and laboratory characteristics and risk factors for severity a...
Jin-jin Zhang, Yi-yuan Cao, Ge Tan, et al.
May 29, 2020
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
CARMEN RIGGIONI, Pasquale Comberiati, Mattia Giovannini, et al.